Profil
Zhanna Jumadilova is currently the Chief Clinical Development Officer at Clarus Therapeutics Holdings, Inc. Prior to this, he was the Vice President-Clinical Development at Insmed, Inc. from 2019 to 2021.
He also worked at AstraZeneca, Inc. as a General Manager.
Jumadilova holds an MBA from Joseph M.
Katz Graduate School of Business and a doctorate from Kazakh National Medical University.
Postes actifs de Zhanna Jumadilova
| Sociétés | Poste | Début |
|---|---|---|
| CLARUS THERAPEUTICS HOLDINGS, INC. | Corporate Officer/Principal | 17/01/2022 |
Anciens postes connus de Zhanna Jumadilova
| Sociétés | Poste | Fin |
|---|---|---|
| INSMED INCORPORATED | Corporate Officer/Principal | 01/10/2021 |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Corporate Officer/Principal | - |
Formation de Zhanna Jumadilova
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Insmed, Inc.
Insmed, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases | Health Technology |
AstraZeneca, Inc.
AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Joseph M. Katz Graduate School of Business
Joseph M. Katz Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kazakh National Medical University
Kazakh National Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Therapeutics Holdings, Inc.
Clarus Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops oral T-replacement therapies | Health Technology |
















